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I.  INTRODUCTION
In the United States, we are often reluctant to talk openly about the
prospect of death or our preferences regarding end of life care. Moreover, we
are reluctant to memorialize our wishes about end of life care in any formal
manner such as an advance directive.1 The causes of this reluctance vary, but 
* Professor of Law, Western New England University School of Law. J.D.
Harvard Law School. An early version of this paper was presented as work in progress to the
faculty at Exeter University Law School on 29 February 2012 and at the Hamline University
School of Law’s End-of-Life Conference on 9 November 2012. Thanks to those in attendance
for their very helpful feedback and to René Reich-Graefe, as always, for his thoughtful
comments and suggestions. © Barbara Ann Noah, 2013. 
1 A recent survey conducted in the U.S. indicated that, while 80 percent of those
surveyed believed that it was important to record their end of life wishes in an advance 
directive, less than a quarter of them had actually done so. Only 40 percent of those surveyed
indicated that they had talked with a loved one about their end of life wishes, and only 8 
percent had been asked about their wishes by their physicians. See Angela Fagerlin & Carl E.
Schneider, Enough: The Failure of the Living Will, 34 HASTINGS CTR. REP. 30, 32, 36 (2004)
























   
   
  
    
    









    
  












240 HAMLINE LAW REVIEW [Vol. 36:2
include discomfort about confronting mortality, a desire to avoid placing a 
burden on family members, and lack of prompting by physicians to consider
these questions.2 This denial of mortality and unwillingness to discuss end of
life options negatively impacts individuals, families, and the health care
system.3 
One-third of Americans die in a hospital despite the fact that most
patients prefer to die at home.4 We spend enormous resources at the end of
life—often with little or no measurable benefit to dying patients.5 Many
patients receive therapeutic care, cardiopulmonary resuscitation, ventilator
support, or ICU care even when death is imminent.6 Physicians also tend to
overestimate the remaining lifespans of seriously ill patients, and are thus
more likely to accede to patient requests for additional interventions.7 At the 
that living wills rarely influence the level of medical care; in fact, at least a quarter of patients
with living wills receive care that is inconsistent with their instructions).
2 Moreover, advance directives, when they do exist, often are of little use in
resolving disputes about end of life care for particular patients. As other commentators have
noted, advance directives rarely resolve end of life disputes; these commentators have 
therefore suggested abandoning efforts to encourage the utilization of advance directives. See,
e.g., Fagerlin & Schneider, supra note 1, at 31, 38–39 (suggesting that, in an attempt to extend 
patients’ exercise of autonomy beyond their span of competence, resources spent to make
living wills routine and even universal but that this policy has not produced results that justify
its costs, and it should therefore be abandoned); John A. Robertson, Second Thoughts on
Living Wills, 21(6) HASTINGS CTR. REP. 6, 6–7 ( 1991) (acknowledging the benefits, at least
superficially, of living wills, but questioning whether they actually provide valid guidance as
to the later-incompetent patient’s wishes and interests). 
3 See generally Barbara A. Noah, In Denial: The Role of Law in Planning for
Death, 21 ELDER L. J. 101 (2013).
4 See Yafu Zhao & William Encinosa, The Costs of End of Life Hospitalizations, 
available at http://www.ncbi.nlm.nih.gov/books/NBK53605/ (last visited Sept. 12, 2012)
(describing data from 2007).  This trend is improving, however.  Recent data suggests that
more people died at home in 2009 than in 2000, although the rate of intensive care unit 
utilization has increased during the same time period.  See Joan M. Teno  et al., Change in
End-of-Life Care for Medicare Beneficiaries: Site of Death, Place of Care, and Health Care
Transitions, 209 JAMA 470, 473 Tbl. 2 (2013).
5 It is well-documented that one-third of medical expenses for the last year of life
are spent in the final month and that aggressive therapies and technologies in that final month 
account for nearly 80 percent of these costs. See Baohui Zhang et al., Health Care Costs in the
Last Week of Life: Associations with End of Life Conversations, 169 ARCH. INTERNAL MED.
480, 482–84 (2009). Moreover, 30 percent of Medicare dollars spent go to care for the 5 
percent of Medicare beneficiaries who die each year. See Amber E. Barnato et al., Trends in
Inpatient Treatment Intensity Among Medicare Beneficiaries at the End of Life, 39 HEALTH
SERV. RES. 363, 363–64 (2004). 
6 See Amresh Hanchate et al., Racial and Ethnic Differences in End-of-Life
Costs: Why Do Minorities Cost More than Whites?, 169 ARCHIVES INTERNAL MED. 493, 497– 
98 (2009) (surveying use of expensive end of life interventions among a large sample of
Medicare beneficiaries and finding patterns of substantial expenditure on life-sustaining
treatment in the final six months of life).
7 Interestingly, the conundrum is more complex that it appears superficially.
Physicians who communicate well with their patients and feel closer to them were more likely 
to over-estimate life expectancy for those patients, suggesting that a close doctor-patient




























                                                                                                                   
    
    
 
   
 
   
 
  
    
  
    
     
  
 
   
 
 241 2013] U.S. AND U.K. END OF LIFE LAW
same time, we under-utilize available resources for pain and symptom
management and other sorts of palliative care.8 These patterns are even more 
marked among racial and ethnic minorities in the United States.9 
In the U.S., the ethical principle of individual patient autonomy has 
long held primary place as a guidepost for making decisions on behalf of
those who have lost decisional capacity.10 Generally stated, the primary goal 
for end of life decision making in the U.S. is to provide care according to the
individual patient’s wishes, either by asking the patient directly or, if the
patient has lost decisional capacity, by attempting to ascertain the patient’s
preferences using advance directives, conversations with family members
and friends, and the context of the patient’s values, preferences, and beliefs.
Under this approach, the ideal is to preserve the patient’s autonomy even 
when he or she can no longer articulate a preference. 
In reality, autonomy in this context is often illusory because there is
insufficient information about the patient’s preferences available, leaving
physicians and family members in a quandary as to whether to continue
providing life-sustaining care. Uncertainty about prognosis in the case of
terminal illness—or possibility of some future recovery of function in the
case of severe brain injury—adds to the complexity of decisions about
withdrawal of life-supportive care. Too frequently, conflicts over these
decisions lead to grief for families or, worse, litigation to resolve what
cannot be resolved through conversation.
By comparison, in the United Kingdom, patient preferences play an
important role in deciding whether to initiate or continue life-supportive 
measures for seriously ill or dying patients, but this principle is deliberately
and openly supplemented with a careful consideration of the patient’s best
interests, particularly when the patient’s wishes are unknown or unclear,
when the physician questions the wisdom of the patient’s choice on medical
grounds, or when resource constraints become a factor.11 Although there are
prognoses. See Nicholas A. Christakis & Elizabeth B. Lamont, Extent and Determinants of
Error in Doctors’ Prognoses in Terminally Ill Patients, 320 BRIT. MED. J. 469, 470–71 (2000)
(finding that, in predicting patients’ remaining life expectancies, physicians were correct only 
20 percent of the time and were over-optimistic 63 percent of the time and concluding that a
closer doctor-patient relationship was associated with over-optimistic predictions); cf. Paul
Glare, Predicting and Communicating Prognosis in Palliative Care, 343 BRIT. MED. J. d5171 
(2011) (“Temporal predictions based on clinical judgment are notoriously inaccurate and
usually overoptimistic. Although probabilistic predictions are more accurate . . . actuarial 
judgment of survival is now recommended. Several statistical models that predict survival
have been developed . . . but none has entered routine clinical practice.”). 
8 See Teno, supra note 4, at 475–76 (describing the ongoing trend of very short 
hospice stays and late referrals to hospice care).
9 See generally Barbara A. Noah, The Role of Race in End-of-Life Care, 15 J.
HEALTH CARE L. & POL’Y 349– 78 (2012).
10 See infra notes 36–37 and accompanying text (discussing dying patients’ rights
in the United States).
11 See infra notes 59–63 and accompanying text (describing the role that doctors
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several very significant differences between the U.S. and the U.K. in terms
of health care delivery, insurance, the role of the physician, and other cultural
variables, there are strong arguments for adopting aspects of the British
approach to end of life decision making and disputes here in the U.S. 
This essay focuses on two cases involving patients in permanent
vegetative states (PVS) for whom little was known about their respective
individual preferences, and it analyzes the differences in conceptualization
and resolution of disputes concerning these patients’ care. It includes an
overview of the different approaches to end of life decision making for
incapacitated patients in the United States and in the United Kingdom.
Finally, the essay considers whether and how U.S. physicians and patients
might more actively incorporate a “best interests” principle into end of life
decision making for patients in PVS. 




The cases of Anthony Bland in the U.K. and Theresa Schiavo in the
U.S. provide contrasting examples of the ways in which physicians, families,
courts, and the public react to cases of young adults in PVS for whom
treatment decisions must be made. Decisions about whether to continue
providing care to patients in PVS are particularly challenging, in the absence
of clear knowledge of the patient’s wishes as previously expressed in an
advance directive or conversations with family or health care providers,
precisely because these patients are neither actively dying nor progressing
towards recovery. The resolution of these cases therefore serves as a
bellwether for the effectiveness of end of life decision making more
generally in their respective countries. 
PVS is a form of unconsciousness that differs from coma.12 Because
patients in PVS experience waking and sleeping cycles, open their eyes,
move their limbs, and utter sounds,13 lay observers sometimes find it difficult
12 See Multi-Society Task Force on PVS, Medical Aspects of the Persistent
Vegetative State, (Pt. I), 330 NEW ENG. J. MED. 1499, 1501 (1994) (hereinafter, Multi-Society
Task Force on PVS) (“[T]he adjective ‘persistent’ refers only to a condition of past and 
continuing disability with an uncertain future, whereas ‘permanent’ implies irreversibility. 
Persistent vegetative state is a diagnosis; permanent vegetative state is a prognosis.”); see also
Roger N. Rosenberg, Consciousness, Coma, and Brain Death—2009, 301 JAMA 1172, 1172 
(2009) (describing PVS as “a syndrome with several causes in which the patient has sustained 
severe brain damage, and in which coma has advanced to a state of wakefulness without
detectable awareness.”). The persistent vegetative state is generally distinguished clinically
from the ‘minimally conscious state,’ “in which the patient exhibits definite responsiveness
that is cognitively driven, rather than unconscious reflexive responses.” Id. at 1172. 
13 See Multi-Society Task Force on PVS, supra note 12, at 1500-01. (“Patients in
a vegetative state are usually not immobile. They may move the trunk or limbs in meaningless 
ways. They may occasionally smile, and a few may even shed tears . . . utter grunts or, on rare





























   
     
     
   
   
 
   
 
   
 
   









     
    
    
 243 2013] U.S. AND U.K. END OF LIFE LAW
to accept that the patient lacks any capacity for thought, emotion, or other
activities associated with consciousness. These patients typically can breathe
without assistance but cannot experience or interact with their environment.
Patients in PVS require comprehensive care, including artificial nutrition and
hydration, to remain alive. With comprehensive care, these patients can live
for many years, yet patients with confirmed permanent vegetative state have
no hope of recovering consciousness or any degree of function.14 
A. Theresa Schiavo 
Several major cases involving young adults in PVS have shaped the 
U.S. jurisprudence addressing disputes over withdrawal of life-sustaining
treatment from patients who are not actively dying. Each of these disputes
involved uncertainty about the quality or quantity of evidence of the
permanently incapacitated patient’s presumed wishes, both because the
patient had no advance directive, and because a family member or the State
was disputing the appropriateness of a health care proxy decision.15 
The most recent of these cases concerned the care of Theresa
Schiavo. In 1990, a sudden cardiac arrest left Theresa Schiavo, aged 26, with
a severe anoxic brain injury leading to PVS.16 Theresa Schiavo spent fifteen
movements . . . .”); cf. Christopher M. Booth et al., Is This Patient Dead, Vegetative, or
Severely Neurologically Impaired?, 291 JAMA 870 (2004) (evaluating data on neurological
outcomes after cardiac arrest, and concluding that several clinical signs that become apparent
just 24 hours after cardiac arrest serve as reliable predictors of poor neurological prognosis).
14 Recent technological developments have allowed physicians to test the
diagnosis of persistent vegetative state. In a small study, approximately 20 percent of recently
diagnosed patients demonstrated signs of consciousness when their brain activity was 
measured with an electroencephalogram (EEG) test. See Benedict Carey, Study Finds Signs of
Awareness in ‘Vegetative’ Patients, N.Y. TIMES, Nov. 9, 2011, at A15; see also Damian Cruse
et al., Bedside Detection of Awareness in a Vegetative State: A Cohort Analysis, 378 LANCET
2088–94 (2011) (assessing 16 patients recently diagnosed with PVS and finding that 3 of
these patients  demonstrated some brain response to commands). In addition to EEG, new
brain imaging technologies such as functional magnetic resonance imaging (fMRI) technology
allows physicians to identify localized neural activity in the brain that was previously
undetectable through observable patient responses. These scans also have called into question
the accuracy of diagnoses of permanent vegetative state, raising questions about the
consequent appropriateness of withdrawal of life-sustaining measures from these patients. See
J. Andrew Billings et al., Severe Brain Injury and the Subjective Life, 40 HASTINGS CTR. REP. 
17, 18–19 (May/June 2010); A. M. Owen et al., Detecting Awareness in the Vegetative State, 
313 SCIENCE 1402 (2006); A. M. Owen et al., Using Functional Magnetic Resonance Imaging
to Detect Covert Awareness in the Vegetative State, 64 ARCH. NEUROL. 1098–1102 (2007);
Rosenberg, supra note 12, at 1173 (describing recent research results).
15 See, e.g., Guardianship of Schiavo, 780 So.2d 176, 177 (2001) (disputing,
among other things, whether it was appropriate for the patient’s husband to continue to serve
as her surrogate decision maker); Cruzan v. Director, Missouri Dept. of Health, 497 U.S. 261,
265 (1990); In re Quinlan, 355 A.2d 647, 651 (1976).
16 The description of events in the Schiavo case is adapted from Barbara A. Noah,
Politicizing the End of Life: Lessons from the Schiavo Controversy, 59 U. MIAMI L. REV. 107,

























   
                                                                                                                   
   
      
   
  
 
   




   
  
 










244 HAMLINE LAW REVIEW [Vol. 36:2
years in a persistent vegetative state sustained by artificial nutrition and 
hydration, along with a host of other types of medical care, although she was
not ventilator dependent. Because of ongoing legal disputes about the
appropriateness of continuing this care, Theresa’s feeding tube was removed
and replaced twice before it was removed for a third and final time and she
was allowed to die. This conflict carried on over many years despite multiple
court determinations that what was known about Theresa’s wishes in this
regard satisfied the standard of evidence required in the state where she
resided for removal of life-sustaining care.17 
From 1998 until 2005, Theresa’s husband, Michael Schiavo, having 
accepted that Theresa would not recover consciousness, sought permission
from the Florida courts to have her feeding tube removed so that she could 
die. Michael based his request on Theresa’s previously expressed wishes and
values, explaining that Theresa would never have wanted to continue to exist
in a vegetative state after all hope of recovery had gone. This testimony was
consistent with the requirement in Florida law that decisions for
incapacitated patients attempt to replicate what they would choose were they
able to express their wishes.18 At the same time, Theresa’s parents vigorously
objected to this request, arguing that the evidence of Theresa’s wishes was
insufficient and that its source was suspect.19 Disputes about the nature of
Theresa’s medical condition confounded the issues. Theresa’s parents found
it difficult to accept that she lacked capacity for thought, emotion or other
activities associated with consciousness.20 Nevertheless, in a series of
judicial decisions, state and federal courts repeatedly confirmed the legal
propriety of acceding to Michael’s request, finding the evidence of Theresa’s
the events and discussing in detail the interference from outside parties in the dispute);
Barbara A. Noah, The Role of Religion in the Schiavo Controversy, 6 HOUSTON J. HEALTH L.
& POL’Y 319, 320–29 (2006) (hereinafter, Noah, Role of Religion) (providing additional
details about the later years of the litigation and external interference from various interest
groups).
17 See supra Noah, Politicizing the End of Life, note 16; see also Steve Haidar &
Kathy Cerminara, Key Events in the Case of Theresa Marie Schiavo, UNIV. MIAMI ETHICS
PROGRAM, available at http://www6.miami.edu/ethics2/schiavo/ schiavo_timeline.html (last
visited Feb. 1, 2013) (providing a detailed chronology of the events of the Schiavo litigation,
including citations to all judicial decisions). 
18 The Florida statute requires that, before a proxy decision-maker may exercise
an incapacitated patient’s right to withdraw life-prolonging measures, the decision must be
supported by “clear and convincing evidence that the decision would have been the one the
patient would have chosen if the patient had been competent.” See  FLA. STAT. § 765.401(3)
(2012).
19 During the controversy, proponents of continued treatment pointed to
suspected marital problems between the couple, and to Michael Schiavo’s decision to live
with and father two children with another woman years after Theresa’s cardiac arrest and
resulting brain injury. These matters became a point of argument for conservative religious
groups who intervened in the case. See Too Vigorously Assisted Suicide, NAT’L REVIEW, Apr. 
11, 2005.
20 See Noah, Role of Religion, supra note 16, at 320–21 (2006) (describing the





































   





 245 2013] U.S. AND U.K. END OF LIFE LAW
wishes legally sufficient to support the removal of life supportive
technology.21 
For over seven years, the legal battle continued between Theresa’s
husband and parents with significant intervention from the Catholic Church,
pro-life organizations, the Florida legislature, and the U.S. Congress.22 The
legal and cultural battle included motions for a new trial, visits to Theresa’s
bedside by a conservative U.S. Senator, death threats against the judge who
issued the orders to remove Theresa’s feeding tube, special legislation from
the Florida legislature giving then Governor Jeb Bush the power to “stay” the
removal of Theresa’s already-removed tube,23 a subpoena from Congress for 
Theresa and Michael Schiavo to “testify” before it, and much political
capitalization from conservative members of Congress on the pro-life aspects
of the case.24 
Finally, in 2005, after a series of state and federal court hearings, the
Florida court once again ordered that the hospice remove Theresa’s feeding
tube. On March 18, 2005, the hospice complied with the court order and
additional frantic legal maneuvering ensued, including motions filed with the
United States Supreme Court, and several Florida courts. Ultimately, all of
the courts that heard the parents’ appeals declined to overturn the order
directing removal of Theresa’s feeding tube for the third and final time. 
Fifteen years after her cardiac arrest, she was allowed to die.25 
B. Anthony Bland
In the United Kingdom, the case of Anthony Bland provides an apt
comparison with that of Theresa Schiavo. On April 15th, 1989, 17 year-old 
21 See Haidar & Cerminara, supra note 17. 
22 Id. See also Noah, Role of Religion, supra note 16, at 333–41 (2006) (focusing
particularly on the role that the Catholic Church played in events and the relevance of the 
Papal declaration that artificial nutrition and hydration are “ordinary care” and must be 
provided under all circumstances).
23 See House Bill 35-E, FLA. STAT. § 418 (2003). The pertinent part of the
legislation provides that:
(1) The Governor shall have the authority to issue a one-time stay to 
prevent the withholding of nutrition and hydration from a patient if, as of
October 15, 2003: (a) That patient has no written advance directive; (b) 
The Court has found that patient to be in a persistent vegetative state; (c)
That patient has had nutrition and hydration withheld; and (d) A member
of that patient’s family has challenged the withholding of nutrition and
hydration. (2) The Governor’s authority to issue the stay expires 15 days
after the effective date of this act, and the expiration of that authority does 
not impact the validity or effect of any stay issued pursuant to this act.
Id. See also Adam Liptak, In Florida Right-to-Die Case, Legislation that Puts Constitution at
Issue, N.Y. TIMES, Oct. 23, 2003, at A14. The bill was popularly known as “Terri’s Law.”






























    
 
                                                 
     
   
   
   
   
   
 
  
   
 
    
  
   
  
246 HAMLINE LAW REVIEW [Vol. 36:2
Anthony Bland was injured in the Hillsborough football ground disaster.26 
His lungs were crushed and punctured, and the supply of oxygen to his brain
was interrupted, leaving him in a permanent vegetative state. Like Theresa
Schiavo, the injury to Anthony’s brain was anoxic, rather than traumatic
(though it resulted from trauma), and thus the injury to the brain was global
rather than localized. Physicians ultimately agreed that there was no hope
that he would recover consciousness. Although, unsurprisingly given his age,
Anthony had never indicated his wishes with respect to life-sustaining
treatment, his father gave evidence that his son would not choose to be left
on life support in these circumstances.27 Unlike in the Schiavo case, the 
entire family concurred. The hospital then sought a declaration that they
could legally discontinue all life-sustaining treatment including artificial
nutrition and hydration.28 
For the first time in British law, the U.K.’s highest court29 ruled that
withdrawal and withholding of medical treatment, including artificial
nutrition and hydration, from patients who lack decisional capacity and who
have no advance directive was permissible. The House of Lords reasoned
that non-consensual treatment violates the principle of self-determination and
that it is only appropriate to treat incapacitated patients without their consent
when their best interests require the treatment.30 As to permanently
unconscious patients, the court concluded that the patient’s interest in being
kept alive has ended (thus no longer justifying treatment), even though 
discontinuation of life support also does nothing to advance the patient’s
interests. The court argued that in these cases, the duty to provide care
ceases.  
Indeed, if the justification for treating a patient who lacks the
capacity to consent lies in the fact that the treatment is
provided in his best interests, it must follow that the
treatment may, and indeed ultimately should, be
26 See Airedale N.H.S. Trust v. Bland 789, 795–96 (1993) (reviewing facts of the
case); see also Hillsborough Disaster and Its Aftermath, BBC News (Dec. 19, 2012) available
at http://www.bbc.co.uk/news/uk19545126 (last visited Jan. 20, 2013) (describing the events 
that led to the deaths of 96 football fans and injuries to hundreds of others).
27 See Airedale N.H.S. Trust v. Bland at 797. 
28 Id. at 796–97
29 At the time of the Bland ruling, the U.K.’s highest appeals court consisted of a 
sub-chamber of the House of Lords. The U.K.’s trial court is called the “High Court.” The
intermediate level is called the “Court of Appeal.” And, as of October 1, 2009, the highest
court is called the “Supreme Court of the U.K.” It is staffed by twelve justices (beginning with
former law lords). 
30 See Airedale N.H.S. Trust at 867. As Lord Goff explained, “[i]f the justification 
for treating a patient who lacks capacity to consent lies in the fact that the treatment is
provided in his best interests, it must follow that the treatment may, and indeed ultimately 
















    













                                                 
   







     




   
 247 2013] U.S. AND U.K. END OF LIFE LAW
discontinued where it is no longer in his best interests to
provide it.31 
The court went on to explain that,
the object of medical treatment and care was to benefit the 
patient, but since a large body of informed and responsible
medical opinion was of the view that existence in the
persistent vegetative state was not a benefit to the patient,
the principle of the sanctity of life, which was not absolute,
was not violated by ceasing to give medical treatment and
care involving invasive manipulation of the patient’s body, 
to which he had not consented and which conferred no
benefit upon him.32 
Implicit in this statement is the fact that, although the court respects the
principle of the sanctity of life, maintaining life alone may not be in a
patient’s best interests if the treatment in question does nothing to improve 
the patient’s condition.
Less than four years after his injury, Anthony Bland’s feeding tube
was removed, and he was allowed to die.33 There was, naturally, a good deal
of public controversy surrounding the Bland case during and after its
litigation and resolution.34 However, the bulk of public reaction about the
case favored the proposed withdrawal of life-supportive measures.35 
Moreover, the debate and a lack of consensus among health care providers
about whether to continue to provide artificial nutrition and hydration to
Anthony Bland never devolved into the kind of political and societal mêlée
that surrounded the Schiavo case in the United States.
31 Airedale N.H.S. Trust v. Bland at 867.
 
32 Id. at 789–90.

33 Kieth McLeod, Families Stand by Their Decisions, SCOTSMAN, Mar. 27, 1997, 

1997 WLNR 2473220 (quoting Anthony’s father, Allan Bland, after the decision to withdraw
Anthony’s feeding tube and allow him to die: “It is all about quality of life, and Tony had 
none. He didn’t recognize you, he never spoke . . .  Everything was done that could be done,
but there was never any hope in our son’s case. Each case should be judged on its merits. It is
a different choice for each family.”).
34 See, e.g., John Keown, Restoring Moral and Intellectual Shape to the Law
After Bland, 113 LAW QUART. REV. 481 (1997) (criticizing the Bland decision both for its
reasoning and its outcome).  
35 See, e.g., James Gosling, Hillsborough Tragedy Doctor Retires, 
ThisisBradford.co.uk, Dec. 2, 2005, 2005 WLNR 19408656 (quoting Anthony’s physician, 
Dr. Jim Howe who described the overwhelming public support from the community, which 
included telling protesters outside the hospital to go away and leave the family alone, and
noting that, in the years that followed, the precedent created by the case resulted in less 
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III. END OF LIFE LAW AND PRACTICES 
A. American End of Life Law and Practices 
Our legal rights of decision making are grounded in the ethical
principle of autonomy and include the right to refuse treatment even if one is
not terminally ill,36 the right to refuse treatment when terminally ill, the right
to continue receiving life-prolonging treatment even when terminally ill 
(though this value becomes subject to dispute if the treatment appears
“futile”), and, in some states, the right to hasten one’s death with the
assistance of a physician.37 However, individuals rarely formalize their
preferences, especially when they are young. Thus, in cases such as the two
described above, surrogate decision makers must face the dilemma and 
choose whether to continue to provide life-sustaining treatment when there is
no hope of recovery. For the most part, medical treatment and decision
making, including end of life decision making, is a matter left to the
individual states.38 End of life decision making in the United States focuses
on patient autonomy as the primary ethical principle and attempts to promote
this autonomy, even when a patient loses decisional capacity, via inquiries
into the patient’s previously expressed wishes, values, preferences, and
36 See, e.g., Bouvia v. Superior Ct., 179 Cal. App. 3d 1127, 225 (1986) (stating
“Petitioner sought to enforce only a right which was exclusively hers and over which neither
the medical profession nor the judiciary have any veto power. The trial court could but
recognize and protect her exercise of that right.”  The case reverses the trial court’s denial of a 
28 year old quadriplegic woman’s petition for writ of mandate to compel hospital officials to 
remove her  feeding tube, thus allowing the patient, consistent with her express wishes, to
die.); see also Alan Meisel, End-of-Life Care, in FROM BIRTH TO DEATH AND BENCH TO
CLINIC: THE HASTINGS CENTER BIOETHICS BRIEFING BOOK, at 51, 51–52  (2008) (“Autonomy
is paramount for patients who possess decision-making capacity, but it is also a major
consideration for patients who lack this capacity. Their wishes must be respected by the 
relatives or other health care proxies who make decisions on their behalf.”). But see Anne
Johnstone, A Matter of Life and Death, GLASGOW HERALD, Jan. 19, 2000, 2000 WLNR
3606774 (describing a bill introduced into the House of Commons by a Pro-Life group of
Members of Parliament that would have allowed for the prosecution of physicians who 
hastened patients’ deaths by withholding “treatment or sustenance,” and the “ecstatic 
welcome” the bill received from the Right to Life lobby group); see also Luke Gormally,
Notes on the Winterton Bill, available at http://www.linacre.org/winterton.html (last visited
Jan. 19, 2013) (writing in support of the bill).
37 See Oregon Death with Dignity Act of 1994, OR. REV. STAT. § 127.800–995;
Washington Death with Dignity Act, R.C.W. 70.245; Baxter v. Montana, 224 P.3d 1211 
(Mont. 2009).
38 One notable exception, the Patient Self-Determination Act (PSDA), represents
a federal effort to encourage the completion of advance directives, with very limited
effectiveness. See U.S. Gov’t Accounting Office, Patient Self-Determination Act: Providers
Offer Information on Advance Directives but Effectiveness Uncertain (1995) (concluding that
“advance directives have been advocated more than they have been used” and that “in general,
only 10 to 25 percent of Americans have documented their end of life choices or appointed a
health care agent”); see also Fagerlin & Schneider, supra note 1 at 32 (commenting on the
empirical studies that demonstrate the PSDA’s lack of effectiveness).
 
 










   
 
 
                                                 
  
 




   

















   
  
  




 249 2013] U.S. AND U.K. END OF LIFE LAW
beliefs.39 All fifty states have incorporated the autonomy principle into their
individual laws, by acknowledging the authority of advance directives or
formally appointed health care proxies,40 though standards of proof for
withdrawing or withholding life-sustaining treatment vary from state to state. 
New York state law, for example, requires clear and convincing
evidence that an incapacitated patient would refuse the treatment being
offered.41 New York also has no statute that formally recognizes the right of
family members to make health care decisions on behalf of incapacitated
patients, which makes surrogate decision making very difficult in
combination with the clear and convincing evidence requirement as
interpreted in that state.42 Missouri,43 and Michigan,44 like New York, require
the highest standard of civil proof, “clear and convincing evidence,” that the
patient would refuse the precise life-supportive measure being used or
39 The American Medical Association (AMA) has acknowledged that patients
have a right of self-determination that includes the right to refuse unwanted medical treatment, 
and that this right is not lost when a patient loses decisional capacity. See Council on Ethical
and Judicial Affairs, AMA, Decisions Near the End of Life, 267 JAMA 2229–33 (1992); see 
also In re Guardianship of Browning, 568 So.2d 4 (Fla. 1990) (affirming the principle that a
person’s right to refuse unwanted medical treatment including life-sustaining treatment 
continues even after the patient has lost the ability to express his preferences).
40 See Meisel, supra note 36, at 52. 
41 See Committee on Science and the Law, Legal Implications of Withdrawal of
Care for Persistently Vegetative Patients, 64 REC. ASS’N CITY OF N.Y. 81, 113 (2009)
(hereinafter, Committee on Science and the Law) (explaining that New York courts have
“reaffirmed the position that decisions to limit life-prolonging treatment for incompetent 
patients required clear and convincing evidence that the patient would have requested those
limitations in the very circumstances and situation being considered, rather than surrogate-
substituted judgment or surrogate judgment made in the patient’s best interests”); see also In
re Eichner, 420 N.E.2d 64, 72 (NY 1981) (“In this case the proof was compelling. . . . There
was . . . no need to speculate as to whether he would want this particular medical procedure to
be discontinued under these circumstances. What occurred to him was identical to what
happened in the Karen Ann Quinlan case, which had originally prompted his decision. . . .
[T]he evidence clearly and convincingly shows that Brother Fox did not want to be
maintained in a vegetative coma by use of a respirator.”); In re Westchester Cnty. Med. Ctr, ex 
rel O’Connor, 531 N.E.2d 607 (1988).
42 See supra Committee on Science and the Law, note 41 at 131 (2009)
(providing a detailed discussion of the law’s approach to care for these patients in the state of
New York.).
43 The Missouri statute explicitly excludes artificial nutrition and hydration from
its definition of “death-prolonging procedure” that may be refused when one is terminally ill. 
Mo. R. Stat. 459.010(3). The statutory definition of terminal illness also appears to exclude
PVS. Mo.R.Stat.459.010(6) (defining terminal illness as “an incurable or irreversible
condition which, in the opinion of the attending physician, is such that death will occur within
a short time regardless of the application of medical procedures.” As the U.S. Supreme Court 
confirmed in the Cruzan decision, the state of Missouri is constitutionally entitled to demand a
standard of clear and convincing evidence that the patient would refuse artificial nutrition and
hydration. See Cruzan v. Director, Missouri Dept. of Health, 497 U.S. 261, 280 (1990).
44 See, e.g., In re Martin 538 N.W.2d 399, 413 (Mich. 1995) (requiring “clear and 
convincing evidence” of previous statements by the now-incapacitated patient that he would 
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contemplated under the precise medical conditions in which he or she finds
him or herself. In these states, only a detailed written advance directive or
well-documented and detailed conversations with a physician or health care
proxy will satisfy this high evidentiary standard. In other states, a hierarchy 
of decision makers for the incapacitated patient, usually the spouse first
followed by the majority of adult children, etc., can use a process of
“substituted judgment” to express their understanding of which options the
patient would choose.45 
Despite this heavy emphasis on the principle of autonomy via 
substituted judgment, U.S. law also includes references to, and consideration
of, the best interests. Many state laws already acknowledge a place for best
interests analysis in making treatment decisions for incapacitated patients.46 
For example, courts have recognized the concept of “proportionate
treatment,” and have suggested that “a treatment course which is only
minimally painful or intrusive may nonetheless be considered
disproportionate to the potential benefits if the prognosis is virtually hopeless
for any significant improvement in condition.”47 In one New York decision,
a court refused to authorize life-prolonging treatment for an incapacitated
adult who had suffered several strokes and had very little cognitive ability.
After she developed gangrene, the hospital wished to perform an amputation
in order to save her life. The court held that incapacitated patients retain their
right to refuse life-sustaining treatment and that the surgery would at best
prolong the dying process while providing “no human or humane benefit” to
her.48 And in a well-regarded New Jersey decision, the New Jersey Supreme 
Court envisioned a sliding scale from pure autonomy-based decision making
to pure best interests-based decision making depending on the quantity and
quality of evidence of the patient’s wishes that is available.49 Nevertheless, 
the New Jersey court was unwilling to apply either of these objective tests to
45 See, e.g., FLA. STAT. CH.765.401 (providing a hierarchy of surrogate decision
makers for a patient who has lost decisional capacity in the absence of an advance directive).
46 Even New York State permits an appointed health care agent to make a
decision, in the absence of information about the patient’s wishes, to withdraw care in
accordance with the patient’s best interests, but it contains an express exception for artificial
nutrition and hydration. Only if the patient has specifically spoken on this matter may the
health care agent request the withdrawal of this type of life-sustaining medical technology.
See N.Y. Health Care Agents and Proxies Law, N.Y. PUB. HEALTH LAW Art. 29-C, § 2982(4).
47 See, e.g., Barber v. Superior Court, 195 Cal. Rptr. 484 (Ct. App. 1983)
(permitting withdrawal of treatment from a comatose patient). 
48 In re Beth Israel Med. Ctr. for Weinstein, 136 Misc.2d 931, 934–35; 942 (N.Y.
Sup. Ct. 1987).
49 In Re Conroy, 98 N.J. 321, 365–66 (1985) (explaining that under a “limited­
objective test,” life-sustaining treatments may be withdrawn or withheld when there is some
reliable evidence that the patient would wish it and when it is clear that the burdens of
continued life with treatment outweigh the benefits and that under a “pure-objective test,”
treatment similarly may be withdrawn or withheld in cases where the “net burdens of the 
patient’s life with the treatment . . . clearly and markedly outweigh the benefits that the patient
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patients in PVS because it argued that such patients, by definition,
experience no burdens of treatment.50 This conclusion deserves scrutiny
because it relies on a very narrow definition of “burden” that presumes that a
patient loses his interest in personal dignity when he can no longer
experience its degradation.51 
Despite this occasional reference to best interests analysis, with very
little exception, U.S. law concerning end of life decision making favors 
continued life-supportive measures when the patient’s wishes are unknown
or ambiguous. As the Schiavo dispute and other cases of its type illustrate,
many individuals take the position that our end of life laws should default on
the side of continued treatment whenever a patient’s choice or best interests
are in dispute and should decline to assess the patient’s quality of that life in
doing so.52 Denying the inevitability of death increases suffering for patients
and their families. Yet, many Americans wish to avoid thinking about death
or quality of life issues, and so stick to the path of “doing everything” for
their loved ones. As a result, U.S. courts often default to this position as well,
since it represents an easy to apply rule when questions of futility arise. 
Given that several opinion polls establish that the majority of people
would prefer not to receive life-sustaining treatment if they are confirmed to
be in a permanent vegetative state,53 and given the astonishing amount of 
health care resources expended in the final months of our lives,54 this
presumption in favor of continued life-supportive measures deserves much
more scrutiny than it typically receives. Why does the law presume that,
50 See In re Peter, 529 A.2d 419, 424–25 (N.J. 1987) (arguing that patients in PVS
“do not experience any of the benefits or burdens that the Conroy balancing tests are intended
or able to appraise”).
51 See infra note 93 and accompanying text (suggesting that dignitary harm 
extends to patients who have permanently lost consciousness). 
52 See, e.g., Conservatorship of Wendland, 28 P.3d 151 (2001) (upholding a trial 
court decision to continue life-sustaining treatment despite a proxy decision-maker’s request
to withdraw it because the proxy “offered no basis for such a finding other than her own 
subjective judgment that the conservatee did not enjoy a satisfactory quality of life and legally
insufficient evidence to the effect that he would have wished to die”); see also In re 
Conservatorship of Helga M. Wanglie, No. PX91283, (Hennepin Cnty., Minn., Prob. Ct.
1991) reprinted in  LAW & MED. 369 (1991) (upholding the surrogate’s request for continued
treatment of the patient, who was in a persistent vegetative state and who died more than a
year later of sepsis); Cruzan v. Director, Missouri Dept. of Health, 497 U.S. 261, 281 (1990)
(“a state may properly decline to make judgments about the ‘quality’ of life that a particular
person may enjoy and simply assert an unqualified interest in the preservation of human life to
be weighed against the constitutionally protected interests of the individual.”). 
53 See, e.g., Press Release, Harris Interactive, By a Near Four-to-One Margin,
U.S. Adults Favor Not Taking Additional Steps to Prolong the Lives of Patients in a Persistent
Vegetative State, Apr. 12, 2005; Lydia Saad, Americans Choose Death Over Vegetative State, 
Gallop (Mar. 29, 2005), available at http://www.gallup.com/poll/15448/
americanschoosedeathovervegetativestate.aspx, (last visited March 3, 2011).
54 Cf. Andrew Stern, REUTERS, Discussing End-of-Life Care Lowers Cost: U.S.
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when a patient’s wishes are unknown, that patient would wish to continue
treatment or life-supportive measures, in particular, given that such a
presumption, when compared with the empirical evidence of people’s
preferences, often will constitute an abrogation of a patient’s autonomous 
right to refuse treatment? Part of the answer is, of course, that keeping a
patient alive “in error” is capable of correction in the future, should
additional information about the patient’s wishes or condition become
available.55 Implicit in this “err on the side of life” mentality is an
unwillingness to make quality of life assessments. A biologic view of life is a
binary view that a person is either “alive” or “dead”; it fails to account for
the range of intermediate levels of unconsciousness or other sorts of
disability or suffering in which a person with decisional capacity might
choose to forego additional life-prolonging treatment. This purely biologic
view of life certainly presents an attractive bright-line rule for courts.56 But
for persons to whom this approach is applied, the presumption in favor of
continued treatment risks demeaning the individual and disregarding his
preferences. Moreover, the argument that continuing with the provision of
existing life-sustaining treatment is merely maintaining the status quo, rather
than making a decision, is a fallacy.57 Continuing treatment is a choice, a
decision as capable of violating a person’s preferences as the decision to
discontinue treatment. Logically, then, the principle of autonomy is a petitio 
principii and incapable of solving the dilemma it creates (or, at least,
perpetuates).  
B. United Kingdom End of Life Law and Practices
The legal system and its impact on medical practice in the United
Kingdom differs significantly from that of the U.S. Rather than a state-by­
state patchwork of statutes and common law opinions, there is a unified
approach to end of life decision making in England, Wales, and Northern
Ireland, and substantively similar standards in Scotland (though with
variations in required procedures). However, there is no formal legislation
that directly regulates end of life care, although aspects of the Mental
Capacity Act of 2005 are relevant.58 
55 Of course, it seems unlikely that “new evidence” of an incapacitated patient’s
wishes is discovered very often.
56 Cf. In re Baby K, 16 F.3d 590 (4th Cir. 1994) (resolving, on technical statutory
grounds, a dispute about continued life supportive measures for an anencephalic infant and
thus defaulting to protection of purely biologic life). 
57 See RONALD DWORKIN, LIFE’S DOMINION 205 (1993) (arguing, in response that
the court has no right to choose to end care for those who have not chosen it themselves, that
“the fallacy in this argument is that choice cannot be avoided. To continue treatment is as
much of a choice as to discontinue it.”).
58 See Mental Capacity Act, available at www.legislation.gov.uk/ukpga/2005/9/ 
contents. In 2008, the U.K. government did, however, make a decision to adopt a systematic 
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Under the current applicable U.K. law, which includes the Mental
Capacity Act (MCA), common law precedent, and guidance documents for
physician practice, the physician retains the ultimate authority to make
treatment decisions for incompetent adults rather than the next-of-kin.59 Even 
the courts do not dictate what happens except to the extent of pronouncing on
the lawfulness of the treatment that the physician proposes.60 However, the 
authority of the physician is limited; the physician must do what is in the
patient’s best interests.61 Courts and the MCA itself have interpreted “best
interests” to include not only medical interests but also the patient’s own
wishes, values, and preferences at the time the patient was competent.62 
Thus, the concept of best interests in the U.K. includes elements of concern
for the patient’s autonomous preferences. The Mental Capacity Act and
accompanying guidance documents also include relevant provisions which
require doctors to act in the best interests of incapacitated patients.63 
In cases of patients in PVS, the General Medical Council (GMC) has
published a Guidance for Doctors on Treatment and Care Towards the End
of Life64 which provides a very different picture of the approach in the U.K.
to these treatment decisions compared with that of the U.S. First, it is worth
noting that, although the publication is called a “guidance” and contains a
disclaimer that it is not a statement of legal principles or a substitute for legal
advice,65 it has the effect of a series of regulatory statements. Doctors are
Approach to Improving End-of-Life Care: A Strategy for Honoring Patients’ Choices, The
Commonwealth Fund, July 2011, at 2, available at http://www.commonwealthfund.org/
Publications/IssueBriefs/2011/Jul/ EnglandsApproachtoImprovingEndofLifeCare.aspx (last
visited Jan. 18, 2013).
59 See Dominic Bell, The Legal Framework for End of Life Care: A United
Kingdom Perspective, 33 INTENSIVE CARE MED. 158, 159 (2006). 
60 Id. at 159.
61 See, e.g., Re A., 1 FLR 549 (2000) (cited in Bell, supra note 59, at 159).
62 U.K. DEP’T OF HEALTH, Good Practice in Consent HSC 2001/023 (2001); GEN.
MED. COUNCIL, Seeking Patients’ Consent: The Ethical Considerations (1998).
63 See Mental Capacity Act, § 4. Section 4(5) adds that, with respect to decisions
about life-sustaining medical treatment, the doctor “must not, in considering whether the
treatment is in the best interests of the person concerned, be motivated by a desire to bring
about his death.” Section 4(6)(a)–(b) adds that the doctor must, in evaluating the patient’s best
interests, also consider the person’s past and present wishes and feelings (and, in particular,
any relevant written statement made by him when he had capacity), [and] the beliefs and
values that would be likely to influence his decision if he had capacity”). According to
Guidance documents, if a patient does not have a relevant advance directive, the physician
may consider withdrawing life-sustaining treatment “based on a range of clinical criteria,
including unresponsive physiological deterioration, overwhelming and irreversible pathology
such as brainstem death, and progression of co-morbidity against a background of significant 
impairment of quality-of-life prior to the critical illness.” GEN. MED. COUNCIL, Treatment and 
Care Towards the End of Life: Good Practice in Decision-making (May 20, 2010)
(hereinafter, GEN. MED. COUNCIL) available at http://www.gmcuk.org 
/static/documents/content/End_of_life.pdf (last visited Feb. 15, 2012).
64 See GEN. MED. COUNCIL, supra note 63. 
65 Id. at 6. In addition to the GEN. MED. COUNCIL’s Guidance, in 2007, the





























                                                                                                                   
 
  
    
   
 






   
  
   
  
   
    
  
   
254 HAMLINE LAW REVIEW [Vol. 36:2
informed that, in cases where the guidance states “you must,” this creates an
overriding duty or principle of practice.66 The nearest equivalents in the U.S.
are professional organizations such as the American Medical Association or
the National Hospice and Palliative Care Organization. These private groups
publish standards, statements of practice or principles of treatment, but they
are not binding on physicians, even on those who are members of the
organizations.
In situations where there is uncertainty about the continued care of
patients who lack decisional capacity and who are in PVS or similar
conditions, the GMC’s guidance strongly emphasizes the patient’s best
interests and recognizes that many patients have not formally stated their
wishes concerning care under these circumstances. The guidance instructs
doctors to use their own “specialist knowledge . . . and clinical judgment,
together with evidence about the patient’s views (including advance
statements, decisions, or directives), to identify which . . . treatments are
clinically appropriate and are likely to result in overall benefit for the
patient.”67 In England and Wales, even though the doctor retains ultimate
treatment decision authority, the  GMC guidance also requires the doctor to
request the appointment of an advocate to participate in the decision making
process when there is no legal proxy or close relative who is willing to stand
in that role for the patient.68 
Where there is disagreement about whether a particular treatment or
intervention would be of overall benefit (either between doctors, or among 
the doctor, his or her patient, or the patient’s family or proxy), the Guidance
sets out a process to resolve the dispute. Interestingly, the Guidance
specifically addresses situations in which the proxy or decision maker 
requests treatment that the doctor believes would not be clinically
Act Code of Practice. This code provides practical guidance to physicians, proxies, paid
carers, independent advocates, and others for the implementation of the MCA’s provisions,
including a thoughtful discussion about what the MCA means by “best interests.” See DEPT.
FOR CONST’L AFFAIRS, Mental Capacity Act of 2005 Code of Practice (2007) 64–91, available
at http://www3.imperial.ac.uk/pls/portallive/docs/1/51771696.PDF (last visited Jan. 12, 2013).
The Code of Practice informs physicians that the MCA does not impose a duty of compliance 
with the Code; “it should be viewed as guidance rather than instruction.” It nevertheless goes
on to say that if one has “not followed relevant guidance contained in the Code then they will 
be expected to give good reasons why they have departed from it.”). Id. at 1.
66 Id. By contrast, in the U.S., doctors are regulated in the state in which they
practice by state boards of medicine, which occasionally work with state legislatures to
promulgate specific standards of practice (often addressing the prescribing of addictive drugs)
and to discipline doctors who violate standards or mistreat or abuse patients. The U.S. state
boards of medicine do not, however, routinely promulgate general standards of practice for
end of life care or any other area of medicine.
67 Id. at 16.
68 Id. at 18 (explaining that the Mental Capacity Act of 2005 requires the
appointment of an Independent Mental Capacity Advocate (IMCA) in such circumstances).
The IMCA has “authority to make enquiries about the patient and to contribute to the decision
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appropriate or of overall benefit to the patient. In these circumstances, the
doctor should explain the reasons for this opinion and discuss it with the
patient’s family. The doctor is not, however, obligated to provide such
treatment.69 
In disputed cases, the Guidance recommends various non-legal 
approaches as a first step, including involving an independent advocate,
seeking advice from a more experienced colleague or obtaining a second
opinion, holding a case conference, or using local mediation services in order
to work toward consensus.70 If none of these steps effectively resolves the
disagreement, the Guidance instructs doctors to seek legal advice by
applying to the appropriate statutory body for review (in Scotland) or to an
appropriate court for an independent ruling.71 The Guidance adds that, in
England, Wales and Northern Ireland, the court should consider “whether
treatment is in the patient’s ‘best interests’” whereas in Scotland the courts
should consider “whether treatment is of benefit to the patient.”72 
The Guidance expressly addresses particularly complex end of life
scenarios as well, including questions about the provision of artificial
nutrition and hydration and issues arising with patients in PVS or who
otherwise lack decisional capacity.73 For patients in PVS or similar
conditions, the Guidance instructs doctors in England, Wales, and Northern
Ireland to approach the appropriate court for a ruling before withdrawing
nutrition and hydration.74 Overall, the Guidance suggests that physicians
have significant authority and even the obligation to decide whether or not
artificial nutrition and hydration are of overall benefit for particular patients. 
69 Id. at 18–19 (providing that the decision maker or proxy can at this point
request a second opinion or seek review from the appropriate statutory body in Scotland or
and appropriate court in the rest of the UK).
70 See GEN. MED. COUNCIL Guidance at 30 (adding that in seeking consensus, the
physician “should take into account the different decision-making roles and authority of those
you consult, and the legal framework for resolving disagreements.”). 
71 See id. at 30. 
72 See id. at 30, n. 22.
73 See generally  GEN. MED. COUNCIL Guidance, §§ 112–27 (discussing the 
provision of clinically assisted nutrition and hydration generally, for patients who have
capacity, for adults who lack capacity with varying prognoses, and for adults in PVS). With
respect to adults who lack capacity and who are not expected to die within hours or days but
who are in the end stage of a disease or condition, the Guidance instructs doctors to provide
artificial nutrition and hydration if it would be of overall benefit to the patient and to take into
account the patient’s wishes and values. See GEN. MED. COUNCIL Guidance at 57 (adding that
“[t]he patient’s request must be given weight and, when the benefits, burdens and risks are
finely balanced, will usually be the deciding factor.”). In these circumstances, if the doctor
believes that artificial nutrition and hydration would not be of overall benefit to the patient, it
can be withheld or withdrawn, but the doctor must obtain a second opinion from another
doctor who is familiar with the patient’s condition but is not directly caring for the patient. Id.
at 57–58 (stating that the doctor should also consider seeking legal advice).
74 Id. at 59 (adding that, although courts in Scotland have not announced this
requirement, doctors would be wise to seek legal advice on whether a court ruling might be
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IV.  SOME COMPARISONS AND OBSERVATIONS
Case law from the United Kingdom suggests that physicians and
courts confronting difficult end of life choices in the U.K. are significantly
more pragmatic about these tragic cases. Beginning with the Bland case, and 
continuing in successor cases,75 there is evidence of a genuine willingness to
consider openly not only the express wishes of the patient (if they are
known), but also, and only together with, the patient’s best interests and
quality of life.  
It is important to note that the court in the Bland case took pains to
characterize a doctor’s removal of life-supportive measures as an omission
(not motivated by a desire to bring about the patient’s death) rather than an
act intended to cause the patient’s death. As Lord Goff suggested:
I agree that the doctor’s conduct in discontinuing life support
can properly be categorised as an omission . . . .
discontinuation of life support is, for present purposes, no
different from not initiating life support in the first place. In
each case, the doctor is simply allowing his patient to die in
the sense that he is desisting from taking a step which might,
in certain circumstances, prevent his patient from dying as a 
result of his pre-existing condition; and as a matter of
general principle an omission such as this will not be
unlawful unless it constitutes a breach of duty to the
patient.76 
Many in the United States agree with this argument for the withdrawal of
life-supportive care. Courts and medical ethics commentators have argued,
persuasively, that withdrawing life support is not “killing” the patient, but
rather allowing the patient to die of the underlying disease or injury which
led to the life support in the first place. It is ceasing to place an artificial
obstacle in the way of what would otherwise be a natural death.77 
But the U.K. court’s willingness to speak directly of the patient’s
“best interests” and to acknowledge that it is not always in a patient’s best
75 The view of the House of Lords as expressed in the Anthony Bland case was 
later confirmed by the House of Lords in 2001 in National Health Service Trust A. v. M. and
N.H.S. Trust B. v. H., 1 All E.R. 801 (2001); 1 F.C.R. 406; 2 W.L.R. 942; 2 F.L.R. 367 
(concurring with the House of Lords’ decision in Bland, taking into account the European
Convention on Human Rights and Fundamental Freedoms (ECHR)); see also Danuta
Mendelson & Timothy Stoltzfus Jost, A Comparative Study of the Law of Palliative Care and
End-of-Life Treatment, 31 J. L. MED. & ETHICS 130, 131 (2003) (discussing these cases).
76 Id. at 866 (distinguishing from this situation the case of “an interloper who 
maliciously switches off a life support machine.”). 
77 See, e.g., In Re Conroy, 486 A.2d 1209, 1224 (1985) (explaining that the
refusal of medical treatment “merely allows the disease to take its natural course; if death 
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interests to continue receiving care which keeps him alive would cause
consternation among many people in the U.S., particularly those who
describe themselves as conservative Christians or “pro-life.” As an example,
Lord Browne Wilkinson in the Bland case expressed the view that physicians
have a responsibility to withdraw life-sustaining medical care when such
treatment is considered futile: 
[i]f there comes the stage where the responsible doctor
comes to the reasonable conclusion (which accords with the
views of a responsible body of medical opinion) that further 
continuance of an intrusive life-support system is not in the
best interests of the patient, he can no longer lawfully
continue that life-support system: to do so would constitute
the crime of battery and tort of trespass to the person.78 
This view has been confirmed repeatedly as a matter of public policy in the
practice of medicine in the U.K.79 
The co-existence of principles of autonomy and beneficence creates
disagreements about the futility of life-supportive medical technology, and
these disputes are embedded into many end of life conflicts. Physicians,
patients, or families may question whether and when further treatment or
life-sustaining measures are no longer medically or ethically appropriate.80 
The futility conundrum is obvious (futility is in the eye of the beholder), and
families, patients, and health care providers may fail to agree on an
appropriate point to discontinue technological interventions. Without
guidance about an individual patient’s beliefs regarding continued life-
supportive measures, it is difficult to know when to cease providing support
to a person whose condition will not improve. In such circumstances, the
U.S. health care system and its providers are reluctant to opine about an
incapacitated patient’s best interests or, underlying that inquiry, quality of
life.81 Instead, courts in these cases generally will revert to erring on the side
of continued treatment.82 
78 Bland at 883 (Lord Browne-Wilkinson).
79 For example, in 2000, the then-chairman of the British Medical Association’s
Medical Ethics Committee spoke strongly in support of the view that treatment should not be
continued when it becomes more of a burden than a benefit to the patient. “Deliberate over-
treatment can be as detrimental as under-treatment.”) See Anne Johnstone, The Arguments
Behind Attempts to Legislate on the Most Agonizing Decision Doctors Have to Make; A
Matter of Life and Death, GLASGOW HERALD, Jan. 19, 2000, 2000 WLNR 3606774 (quoting
Dr. Michael Wilks).
80 Futility questions arise in two categories: questions of the subjective value of
the medical intervention and questions about the probability that the medical intervention will
be successful. See Robert D. Truog et al., The Problem with Futility, 326 NEW ENG. J. MED. 
1560, 1561 (1992).
81 See, e.g., Cruzan v. Dir., Mo. Dept. of Health, 497 U.S. 261, 282 (1990) (“[W]e
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With the continual advancement of life-supportive technologies, we
add to our arsenal for delaying death. A decision to maintain the status quo
and continue life-supportive measures may help assuage feelings of
helplessness on the part of families and care givers, and it may align with the
interests of “pro-life” organizations, but it is not necessarily in the individual
patient’s best interests, nor does it necessarily reflect the patient’s authentic
choice.83 As explained above, a purely biologic view of life presents an easy
to apply bright-line rule for U.S. courts.84 Any willingness to look beyond 
mere biologic existence would require that physicians and families consider
whether technologies that extend life provide a benefit to patients in cases in
which the patient will experience no improvement in function. Too often,
rather than address uncomfortable quality of life questions, we in the U.S.
sidestep these ethically challenging decisions. The problem with this
preference in the direction of continued treatment is that it is just as likely to
offend an individual’s autonomy as to err in the opposite direction and
withdraw treatment.
Part of the particular difficulty with discussing death in the U.S.
probably stems from the heterogeneity of its culture. While the United States
takes pride in its religious and cultural pluralism, it struggles with the
resultant differences when attempting to reach a collective, societal
consensus on end of life matters. The mainstream culture in the U.S. is
individual may enjoy, and simply assert an unqualified interest in the preservation of human 
life to be weighed against the constitutionally protected interests of the individual.”);
Conservatorship of Wendland, 28 P.3d 151 (2001) (upholding a trial court decision to
continue life-sustaining treatment despite a proxy decision maker’s request to withdraw it
because the proxy “offered no basis for such a finding other than her own subjective judgment
that the conservatee did not enjoy a satisfactory quality of life and legally insufficient 
evidence to the effect that he would have wished to die”); In re Conservatorship of Helga M.
Wanglie, No. PX91283, (Hennepin Cnty. Prob. Div., Minn. 1989) (upholding the surrogate’s
request for continued treatment of the patient, who was in a persistent vegetative state and
who died more than a year later of sepsis).
82 See, e.g., Cruzan at 283 (“An erroneous decision not to terminate [life­
supportive measures] results in a maintenance of the status quo; the possibility of subsequent
developments such as advancements in medical science, the discovery of new evidence 
regarding the patient’s intent, . . . at least create the potential that a wrong decision will 
eventually be corrected . . . . An erroneous decision to withdraw life-sustaining treatment,
however, is not susceptible of correction”); see also Alicia R. Ouellette, When Vitalism is
Dead Wrong: The Discrimination Against and Torture of Incompetent Patients by
Compulsory Life-Sustaining Treatment, 79 IND. L. J. 1 (2004) (arguing that people in the U.S.
err on the side of life by defining it as biological life in order to avoid having to draw the line
between euthanasia and determining that the patient’s best interests might involve ceasing 
life-sustaining care).
83 Cf. Sean Palfrey, Daring to Practice Low-Cost Medicine in a High-Tech Era, 
NEW ENG. J. MED. (2011), available at http://www.nejm.org/doi/pdf/10.1056/
NEJMp1101392?ssource’hcrc (last visited Mar. 3, 2012) (commenting on the mistaken belief
that “‘doing everything’ is the best practice and the way to prevent harm”).
84 Cf. In re Baby K, 16 F.3d 590 (4th Cir. 1994) (resolving, on technical statutory
grounds, a dispute about continued life supportive measures for an anencephalic infant and
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heavily divided on the most challenging issues in end of life care. This
divisiveness, with respect not only to end of life care but also reproductive
autonomy, is often referred to as the “culture wars.” The mechanisms of
legal adjudication go some way to creating consensus by recognizing some 
fundamental rights of decision making, but when an individual’s wishes are
unclear and a dispute reaches the judicial system, our cultural heterogeneity
adds fuel to the ensuing conflict.85 
In the U.S., many hold the view that life begins at conception and
that all life is sacrosanct, even if the person in question is permanently and
irretrievably unconscious. By contrast, British courts have taken the position
that “a view that life must be preserved at all costs does not sanctify life.”86 
As Lord Justice Hoffmann wrote in the Bland case, “ [t]he choice which the
law makes must reassure people that the courts do have full respect for life,
but that they do not pursue the principle to the point at which it has become
almost empty of any real content and when it involves the sacrifice of other
important values such as human dignity and freedom of choice.”87  This is a
difficult line to draw, but well worth the effort.
V. IN THE U.S.A.: ROLE FOR BEST INTERESTS ANALYSIS
Although there are many differences between the U.S. and the U.K.
law governing decision making for incapacitated patients, two stand out.
First, the primacy of the autonomy principle in the U.S. means that
physicians are rarely called upon to make the actual decision about whether
to withdraw life sustaining medical treatment. Physicians are asked to
implement decisions made by patients (via advance directives) or their
proxies, but they rarely possess the responsibility or authority to decide
(although of course physicians must provide the necessary information on
which to base the decision and they also retain the right to refuse to
implement a patient’s or proxy’s request to withdraw care).88 In contrast,
physicians in the U.K. are expressly charged with the responsibility to
85 Cf. Douglas B. White & Thaddeus M. Pope, The Courts, Futility, and the Ends
of Medicine, 307 JAMA 151, 151-52 (2012) (discussing the collateral benefits of judicial
adjudication of end of life disputes).
86 In re a Ward of the Court, 2 I.R.L.M. 401 (S.C.) (Ir. 1995) (adding that
“sanctity of life was not a principle on which legal structures should be based since it
depended on a religious outlook that not everyone shared.”); also cited in Bell, supra note 59, 
at 160.
87 See Airedale NHS Trust v. Bland, at 830. 
88 The Texas Advance Directives Act is a rare example of a statute that allows
health care facilities to discontinue life-sustaining medical treatment in cases where the
treating physicians believe that continuing such care is medically or ethically inappropriate.
See Texas Advance Directives Act, Section 166.046(e) (1999). Three other state medical
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determine whether continuing life-sustaining medical treatment is
appropriate under the law.
Second, as explained above, the principle of autonomy, despite its
inherent weaknesses, is frequently interpreted by courts in the U.S. to
exclude any consideration of best interests, including quality of life or the
concept of dignitary harm, except to the extent that the patient or proxy has
included these considerations in their expressed wishes. The autonomy
principle may be understood to include best interests analysis, but only if the
individual patient wants it so. In contrast, the best interests principle is
paramount in the U.K. and includes within it the wishes of the patient
(autonomy). The British approach therefore adds a layer of pragmatism into
the decision, by taking into account the best available information about the
patient’s prognosis and the likely effectiveness of proposed therapeutic
interventions. 
What does it really mean to do “what the patient would choose if
able”? In the current U.S. approach, when we do not know a patient’s
wishes, we either 1) err on the side of continued treatment as a default
position or 2) make a mixed autonomy and best interests decision or a pure
best interests analysis without necessarily being explicit about it. In other
words, autonomy often is simply not enough to make a determination about
the ethical propriety of continuing life-supportive measures for a patient in
PVS. Increasing the rate at which patients make advance directives also will
not solve the problem of treatment of patients in PVS because, even when
these documents are available, they may have limited application under state
law.89 About one-third of states exclude permanent unconsciousness as a
condition for which advance directives can be drafted to direct the
withdrawal of care.90 And at least three-quarters of states allow individual
health care providers to refuse to carry out a patient’s wish for withdrawal or
withholding of life-sustaining treatment, either for reasons of conscience, or
for no reason at all.91 Finally, advance directives made in the past may not be
accurate predictors of what a now-capacitated individual would actually
choose under the exact circumstances when later incapacitated by illness.92 
89 States frequently limit applicability of advance directives to terminal illness,
leaving patients who suffer from chronic and debilitating disease (including PVS) with more
limited options, such as the appointment of a health care proxy. See Robertson, supra note 2,
at 6; see also Fagerlin and Schneider, supra note 1, at 31.
90 See Stephen Arons, Current Issues in End-of-Life Care, in BERZOFF &
SILVERMAN, LIVING WITH DYING, 730, 734 (Joan Berzoff and Phyllis R. Silverman, eds., 
2004).
91 Id. at 734; see also Neil J. Farber et al., Physicians’ Decisions to Withhold and 
Withdraw Life-Sustaining Treatment, 166 ARCH. INT. MED. 560, 563 (2006) (describing
research that indicated that nearly half of a cohort of physicians surveyed would refuse to 
comply with patient’s wishes to withdraw or withhold life supportive technology under some
circumstances).
92 See Robertson, supra note 2, at 8 (noting that those who execute advance 
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By incorporating an additional layer of consideration of a patient’s
best interests in situations where there is little or nothing known about the
patient’s actual wishes, U.S. physicians can, consistent with existing law in 
many states, initiate conversations with more content about the desired
versus realistic ends of continuation of care. Because autonomy is still very
much part of the conversation, those patients or surrogates who believe that
any life, even permanently unconscious life, is preferable to death can
continue to request life-supportive measures. A best interests approach could
add consideration of the benefits and burdens of continued treatment
(including in a concept of burdens that includes dignitary harm) into the mix,
and can help the physician and family or surrogate move toward a plan of
treatment or non-treatment. For example, in the Bland case, it was argued, in
support of withdrawing artificial nutrition and hydration, both that
continuing treatment would be of no benefit because it could not reverse his
condition and that keeping Anthony alive under these circumstances, when
he would most likely not wish it, diminished his dignity.93 
This is not to suggest that a U.S. physician impose his or her
assessment of the patient’s best interests and then dictate the course of
treatment (or non-treatment) accordingly. What is recommended here is that
U.S. physicians learn to move beyond the autonomy conversation (what
would your loved one choose if she were able?) to articulate the facts about
the patient’s chances for meaningful recovery and the benefits and burdens
of continued treatment and life-supportive measures for patients in PVS with
a medically confirmed diagnosis. The data suggest that, when discussing the
prognosis of seriously ill patients with patients and their family members, 
physicians frequently shy away from disclosing these details
spontaneously.94 
may not be a good indicator of their interests as an incompetent patient”); see also Fagerlin &
Schneider, supra note 1, at 33 (arguing that people will have difficulty predicting their 
preferences in advance because they misunderstand illnesses and treatments, think about their
“choices” only superficially, and change their minds over time).
93 See Airedale NHS Trust v. Bland, at 883. In response to those who object that it
cannot burden a person’s dignity to keep him alive if he cannot feel pain or humiliation,
commentators have pointed out, quite persuasively, that this argument “assumes that we have
no interests except in those things of which we have conscious experience. But this does not
accord with most people’s intuitive feelings about their lives and deaths.” See  DWORKIN,
supra note 57, at 206 (adding, with respect to Anthony Bland’s interests, that it is “demeaning
to the human spirit to say that, being unconscious, he can have no interest in his personal
privacy and dignity, in how he lives or dies.”).
94 Physicians also tend to over-estimate the remaining life spans of seriously ill
patients and to convey prognosis in overly optimistic terms. See Nicholas A. Christakis &
Elizabeth B. Lamont, Extent and Determinants of Error in Doctors’ Prognoses in Terminally
Ill Patients, 320 BRIT. MED. J. 469, 470–71 (2000) (finding that, in predicting patients’
remaining life expectancies, physicians were correct only 20 percent of the time and were
over-optimistic 63 percent of the time and concluding that a closer doctor-patient relationship
was associated with over-optimistic predictions). Even worse, a surprising number of
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All of this, of course, will require some physicians to develop better
communication skills and a willingness to use them, even in circumstances
that are emotionally challenging for physician, patient, and family.
Ultimately, if the permanently vegetative patient has no relevant advance
directive and conversations about what the patient would choose are
unavailing, and the family member or surrogate decision maker is unable or
unwilling to make a decision about continued treatment or life-supportive
measures, the physician or medical team should take more initiative in
having the necessary conversation. When a patient’s diagnosis of permanent
vegetative state is confirmed and life supportive measures are the only thing
standing between that person and death, physicians can do more to honor a
patient’s choices and dignity by including truthful conversations about
prognosis and quality of life. As one commentator recently suggested,
physicians should ask what the patient or family wants to know and then tell
the truth in an understandable and clear way about the time that the patient
has left and what he or she can expect.95 Physicians who undertake these
conversations acknowledge that they are difficult, and that it is often easier to
let the patient be swept away by “the powerful momentum of modern
medicine.”96 Better physician training regarding communication and 
understanding of legal and ethical standards for withdrawal and withholding
of life-sustaining care is sorely needed.97 Although it is also the case in the
U.S. (as in the U.K.) that physicians have no ethical or legal obligation to
provide clinically inappropriate treatment, the combined force of
disagreement about what might be clinically appropriate, fear of malpractice 
liability, and emotional pressure from a family will frequently lead to
continued treatment. In other words, in the U.S., the doctor may take the path
of least resistance.
a recent survey of physicians, one in ten physicians admitted to lying to a patient within the
previous year and over half of those surveyed acknowledged that they had been unreasonably
optimistic about a patient’s prognosis. See Lisa I. Iezzoni et al., Survey Shows That at Least
Some Physicians Are Not Always Open or Honest with Patients, 31 HEALTH AFFAIRS 383,
383–88 (2012); cf. Arato v. Avedon, 858 P.2d 598 (1993) (involving a claim by a deceased
patient’s family that the physicians’ failure to disclose specific information about survival
rates and times with pancreatic cancer and related cases impaired the patient’s ability to get 
his financial and business affairs in order).
95 See Thomas J. Smith & Dan L. Longo, Talking With Patients About Dying, 367 
NEW ENG. J. MED. 1651, 1652 (2012).
96 See Mark Vierra, Death Panels, 156 ANN. INTERNAL MED. 394, 395 (2012)
(describing a case in which he explained to a dying patient’s wife why he would not
recommend additional life-prolonging surgery and adding that “[e]very one of my patients is
going to die one day. Like it or not, I should have these conversations earlier, more often, and
more comfortably. If that makes me part of a death panel, well, I suppose I can live with 
that.”).
97 See Neil J. Farber et al., Physicians’ Decisions to Withhold and Withdraw Life-
Sustaining Treatment, 166 ARCH. INT. MED. 560, 563 (2006) (noting that lack of training
about the ethical and legal issues may lead to dissent among physicians when patients request
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Of course, completely abandoning the principle of autonomy in U.S. 
end of life decision making law is unwise and unnecessary. There is no need
to revise state laws that emphasize the role of patient autonomy. It is
essential, however, to recognize that autonomy alone, as an ethical and legal
principle, represents an insufficient basis for end of life decision making in
many instances. While it is true that, in the end, we must each confront death
individually in our own way, the “good death” envisioned by most requires
that patients surrender control over the externalities of medical care at some 
point and trust that those who provide that care will do what it takes to ease
the path and not to prolong it in conflict with a patient’s best interests.98 
VI.  CONCLUSION
How we die matters on multiple dimensions. Although this paper
focuses on patients in PVS and similar conditions, it obviously matters to all
patients. Addressing death in a compassionate but pragmatic manner has the
potential to make the experience of physicians who care for dying patients
more meaningful and complete, exert a positive impact on health care
systems (both in terms of the economic bottom line and the allocation of
resources in ways that maximize health for all), and benefit the societies in
which we live.  
In general, it seems that, while both the U.S. and the U.K. systems
respect autonomy as a fundamental principle of health care decision making, 
once a patient has lost decisional capacity and the patient’s wishes are
unknown or uncertain, the U.K. system is much more willing openly to
consider the patient’s best interests, especially the benefits versus burdens of
continued treatment and the risk that continuing treatment with no hope of
improvement burdens a patient’s dignity. And unlike in the U.S., in the U.K.
there is much less of a pattern of erring on the side of continued treatment if
the patient has no hope of making any significant recovery.
Of course, there will be some who worry that leaving too much 
decision making authority in the hands of physicians allows for paternalism
and the risk of discrimination. In the case of withdrawing life-sustaining
measures from patients in PVS, it appears that the safeguards recommended 
by the GMC address these concerns effectively. The emphasis on autonomy
in the U.S., and the unwillingness of many doctors to say, definitely, that
further life-sustaining care is inappropriate, generates financial and
psychological costs to U.S. patients, the health care system, and society as a
whole. Allowing a patient to languish in a vegetative state over a period of
Cf.  MARTHA ALBERTSON FINEMAN, THE AUTONOMY MYTH (2005) (arguing
that, because each individual in society is “inevitably dependent” at various stages of life such
as childhood and old age, society should recognize and promote “caretaking relationships”
rather than traditional family structures and should acknowledge that traditional American
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many years after it has been confirmed that there is no chance of recovery
does that patient an injury to his dignity and, most likely, his autonomy even
if the patient is unaware of his condition. 
Some aspects of the British approach to incorporating a best interests
analysis into end of life decision making can and should receive more 
explicit consideration in American health policy, especially via medical
training and continuing medical education for physicians and other health
care providers. Although it is unlikely that the U.S. legal framework will
change substantially in matters of end of life care, we can, as physicians,
patients, and families learn to think differently about these difficult
questions. And, if we truly value autonomy, our laws and the end of life
practices that operate within them must do more to protect incapacitated
patient’s choices from those who may by default or deliberation impose their
personal views about the sanctity of life on others.
